Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1128075 | 0.98 | GLA (0.61) | GLAPAOXCYP1A2MAPK1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL23453856 | 0.98 | GLA (0.61) | GLAPAOXCYP1A2MAPK1SMN1; SMN2 | |
| SCHEMBL8194848 | 0.98 | GLA (0.55) | GLAPAOXCYP1A2MAPK1SMN1; SMN2 | |
| SCHEMBL21122189 | 0.92 | GLA (0.50) | GLAPAOXCYP1A2MAPK1SMN1; SMN2 | |
| SCHEMBL24732015 | 0.92 | CYP1A2 (0.52) | GLAPAOXCYP1A2MAPK1SMN1; SMN2 | |
| SCHEMBL3973280 | 0.90 | GLA (0.67) | GLAPAOXCYP1A2MAPK1SMN1; SMN2 | |
| SCHEMBL1069692 | 0.90 | — | — | |
| SCHEMBL6536452 | 0.90 | GLA (0.67) | GLAPAOXCYP1A2MAPK1SMN1; SMN2 | |
| SCHEMBL7027263 | 0.90 | GLA (0.67) | GLAPAOXCYP1A2MAPK1SMN1; SMN2 | |
| Propane SCHEMBL1995071 | 0.88 | GLA (0.59) | GLAPAOXCYP1A2MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 390 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025080945-A1 | LIPID NANOPARTICLES | CodeBridgeBio Inc. (US) | 2025-04-17 | — | — | WO | claimed |
| EP-2968145-A1 | MODIFIED DOCETAXEL LIPOSOME FORMULATIONS | Mallinckrodt LLC (US) | 2016-01-20 | — | — | EP | claimed |
| CN-105188675-A | Modified docetaxel liposome formulations | MALLINCKRODT LLC | 2015-12-23 | — | — | CN | claimed |
| WO-2014160392-A1 | MODIFIED DOCETAXEL LIPOSOME FORMULATIONS | MALLINCKRODT LLC (US) | 2014-10-02 | — | — | WO | claimed |
| WO-2000026195-A1 | NOVEL AMINO ACID HETEROCYCLIC AMIDE DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | G.D. SEARLE & CO. (US) | 2000-05-11 | — | — | WO | claimed |
| EP-0494956-B1 | AMINOCARBOXYLATE SALTS AS CORROSION INHIBITORS IN COATING APPLICATIONS | COSAN CHEM CORP (US) | 1995-12-13 | — | — | EP | claimed |
| US-20260115138-A1 | LIPID NANOPARTICLES | CODEBRIDGEBIO INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-3814356-B1 | TRIAZOLOTRIAZINE DERIVATIVES AS A2A RECEPTOR ANTAGONISTS | ZHEJIANG VIMGREEN PHARMACEUTICALS LTD (CN) | 2026-03-11 | — | — | EP | disclosed |
| EP-3858849-B1 | DERIVATIVE BASED ON COMMON ANEMARRHENAE RHIZOME SARSASAPOGENIN STRUCTURE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | PHYTOVENT BIOPHARMA (CN) | 2026-02-11 | — | — | EP | disclosed |
| US-12479826-B2 | Pyridazinyl amino derivatives as ALK5 inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2025-11-25 | — | — | US | disclosed |
| EP-4635939-A1 | NOVEL LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION COMPRISING SAME | Korea Institute of Science and Technology (KR) | 2025-10-22 | — | — | EP | disclosed |
| US-12448410-B2 | Derivative of sarsasapogenin, pharmaceutical composition and use thereof | PHYTOVENT BIOPHARMA (CN) | 2025-10-21 | — | — | US | disclosed |
| US-12427111-B2 | Lipid nanoparticles | CodeBridgeBio Inc. (US) | 2025-09-30 | — | — | US | disclosed |
| WO-2002066462-A1 | PYRAZOLE DERIVATIVES AGAINST TGF OVEREXPRESSION | GLAXO GROUP LIMITED (GB) | 2002-08-29 | — | — | WO | disclosed |
| WO-2002004434-A1 | COLCHINOL DERIVATIVES AS VASCULAR DAMAGING AGENTS | ANGIOGENE PHARMACEUTICALS LIMITED (GB) | 2002-01-17 | — | — | WO | disclosed |
| WO-2000023419-A1 | NOVEL PRODRUGS OF NON-STEROIDAL ANTI-INFLAMMATORY CARBOXYLIC ACIDS, THEIR PREPARATION AND USE | JAERVINEN TOMI (FI) | 2000-04-27 | — | — | WO | disclosed |
| EP-0494956-B1 | AMINOCARBOXYLATE SALTS AS CORROSION INHIBITORS IN COATING APPLICATIONS | COSAN CHEM CORP (US) | 1995-12-13 | — | — | EP | disclosed |
| EP-0494956-A4 | AMINOCARBOXYLATE SALTS AS CORROSION INHIBITORS IN COATING APPLICATIONS | — | 1993-07-21 | — | — | EP | disclosed |
| EP-0494956-A1 | AMINOCARBOXYLATE SALTS AS CORROSION INHIBITORS IN COATING APPLICATIONS. | COSAN CHEM CORP (US) | 1992-07-22 | — | — | EP | disclosed |
| WO-1991004952-A1 | AMINOCARBOXYLATE SALTS AS CORROSION INHIBITORS IN COATING APPLICATIONS | COSAN CHEMICAL CORPORATION (US) | 1991-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115138-A1 | LIPID NANOPARTICLES | LDLR, CETP, PLIN3 | GLA 3886/4885PAOX 587/4885CYP1A2 4669/4885 |
| US-12479826-B2 | Pyridazinyl amino derivatives as ALK5 inhibitors | ALK, TGFBR1, ACVR1 | GLA 2296/4885PAOX 2033/4885CYP1A2 3069/4885 |
| US-12427111-B2 | Lipid nanoparticles | PNLIP, PLIN3, LIPG | GLA 2929/4885PAOX 802/4885CYP1A2 4683/4885 |
| US-12448410-B2 | Derivative of sarsasapogenin, pharmaceutical composition and use thereof | SARS1, ACE2, FURIN | GLA 464/4885PAOX 3066/4885CYP1A2 1505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.